| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/SLA.0B013E318153FDCB |
| P698 | PubMed publication ID | 18376183 |
| P50 | author | Frans Moll | Q57298480 |
| Marianne C. Verhaar | Q40340965 | ||
| P2093 | author name string | Daniel J Lips | |
| Ralf W Sprengers | |||
| P2860 | cites work | Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs | Q31113638 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | limb ischemia | Q18553514 |
| P304 | page(s) | 411-420 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Progenitor cell therapy in patients with critical limb ischemia without surgical options | |
| P478 | volume | 247 |
| Q36944312 | A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia |
| Q34496411 | A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study. |
| Q33722293 | Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy |
| Q36870189 | Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? |
| Q33843965 | Always contact a vascular interventional specialist before amputating a patient with critical limb ischemia |
| Q36428933 | Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering |
| Q36014060 | Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. |
| Q34572612 | Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia. |
| Q36923569 | From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T. |
| Q90115248 | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia |
| Q45861381 | Impact of angiogenic therapy in the treatment of critical lower limb ischemia in an animal model. |
| Q37510919 | Improvement in Blood Supply After "Heparin-Dextran" Therapy in Patients of Buerger's Disease with Critical Limb Ischemia |
| Q36472391 | Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model |
| Q37234751 | Insights into mechanisms behind arteriogenesis: what does the future hold? |
| Q40035321 | Intra-arterial autologous bone marrow cell transplantation in a patient with upper-extremity critical limb ischemia. |
| Q37322166 | Review article: endothelial progenitor cells in renal disease |
| Q45731764 | Role of serum levels of angiogenic cytokines in assessment of angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia. |
| Q45868651 | Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study. |
| Q36262074 | Stem cell therapy for critical limb ischaemia - a review |
| Q34331206 | Stem cell trials for cardiovascular medicine: ethical rationale |
| Q37734560 | Therapeutic angiogenesis for the management of refractory angina: current concepts |
| Q34353144 | Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis |
| Q38100692 | Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach |
Search more.